Perioperative chemotherapy with modified FOLFIRINOX for nonmetastatic pancreatic cancer: a new standard of care?

被引：0
作者：
Radi, Imad [1 ]
Samaha, Ramy [1 ]
Hajj, Joanna El [1 ]
Samaha, Hady [1 ]
Kourie, Hampig Raphael [1 ]
机构：
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Fac Med, Beirut 166830, Lebanon
来源：
FUTURE ONCOLOGY | 2021年 / 17卷 / 03期
关键词：
borderline resectable; locally advanced; modified FOLFIRINOX; pancreatic cancer; pancreatic surgery; perioperative chemotherapy; ADJUVANT CHEMOTHERAPY; GEMCITABINE; RESECTION; EFFICACY;
D O I：
10.2217/fon-2020-0836
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：229 / 233
页数：5
相关论文
共 34 条
  • [1] Surgical Outcome Results From SWOG S1505 A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma
    Ahmad, Syed A.
    Duong, Mai
    Sohal, Davendra P. S.
    Gandhi, Namita S.
    Beg, Muhammad Shaalan
    Wang-Gillam, Andrea
    Wade, James L., III
    Chiorean, Elena Gabriela
    Guthrie, Katherine A.
    Lowy, Andrew M.
    Philip, Philip A.
    Hochster, Howard S.
    [J]. ANNALS OF SURGERY, 2020, 272 (03) : 481 - 486
  • [2] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
    Al-Batran, Salah-Eddin
    Homann, Nils
    Pauligk, Claudia
    Goetze, Thorsten O.
    Meiler, Johannes
    Kasper, Stefan
    Kopp, Hans-Georg
    Mayer, Frank
    Haag, Georg Martin
    Luley, Kim
    Lindig, Udo
    Schmiegel, Wolff
    Pohl, Michael
    Stoehlmacher, Jan
    Folprecht, Gunnar
    Probst, Stephan
    Prasnikar, Nicole
    Fischbach, Wolfgang
    Mahlberg, Rolf
    Trojan, Joerg
    Koenigsmann, Michael
    Martens, Uwe M.
    Thuss-Patience, Peter
    Egger, Matthias
    Block, Andreas
    Heinemann, Volker
    Illerhaus, Gerald
    Moehler, Markus
    Schenk, Michael
    Kullmann, Frank
    Behringer, Dirk M.
    Heike, Michael
    Pink, Daniel
    Teschendorf, Christian
    Loehr, Carmen
    Bernhard, Helga
    Schuch, Gunter
    Rethwisch, Volker
    von Weikersthal, Ludwig Fischer
    Hartmann, Joerg T.
    Kneba, Michael
    Daum, Severin
    Schulmann, Karsten
    Weniger, Joerg
    Belle, Sebastian
    Gaiser, Timo
    Oduncu, Fuat S.
    Guentner, Martina
    Hozaeel, Wael
    Reichart, Alexander
    [J]. LANCET, 2019, 393 (10184) : 1948 - 1957
  • [3] Chakraborty S, 2013, ANN GASTROENTEROL, V26, P346
  • [4] Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy
    Cheng, TY
    Sheth, K
    White, RR
    Ueno, T
    Hung, CF
    Clary, BM
    Pappas, TN
    Tyler, DS
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (01) : 66 - 74
  • [5] FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
    Conroy, T.
    Hammel, P.
    Hebbar, M.
    Ben Abdelghani, M.
    Wei, A. C.
    Raoul, J. -L.
    Chone, L.
    Francois, E.
    Artru, P.
    Biagi, J. J.
    Lecomte, T.
    Assenat, E.
    Faroux, R.
    Ychou, M.
    Volet, J.
    Sauvanet, A.
    Breysacher, G.
    Di Fiore, F.
    Cripps, C.
    Kavan, P.
    Texereau, P.
    Bouhier-Leporrier, K.
    Khemissa-Akouz, F.
    Legoux, J. -L.
    Juzyna, B.
    Gourgou, S.
    O'Callaghan, C. J.
    Jouffroy-Zeller, C.
    Rat, P.
    Malka, D.
    Castan, F.
    Bachet, J. -B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) : 2395 - 2406
  • [6] FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
    Conroy, Thierry
    Desseigne, Francoise
    Ychou, Marc
    Bouche, Olivier
    Guimbaud, Rosine
    Becouarn, Yves
    Adenis, Antoine
    Raoul, Jean-Luc
    Gourgou-Bourgade, Sophie
    de la Fouchardiere, Christelle
    Bennouna, Jaafar
    Bachet, Jean-Baptiste
    Khemissa-Akouz, Faiza
    Pere-Verge, Denis
    Delbaldo, Catherine
    Assenat, Eric
    Chauffert, Bruno
    Michel, Pierre
    Montoto-Grillot, Christine
    Ducreux, Michel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) : 1817 - 1825
  • [7] Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
    Ferrone, Cristina R.
    Marchegiani, Giovanni
    Hong, Theodore S.
    Ryan, David P.
    Deshpande, Vikram
    McDonnell, Erin I.
    Sabbatino, Francesco
    Santos, Daniela Dias
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Faris, Jason E.
    Goyal, Lipika
    Kwak, Eunice L.
    Murphy, Janet E.
    Ting, David T.
    Wo, Jennifer Y.
    Zhu, Andrew X.
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    [J]. ANNALS OF SURGERY, 2015, 261 (01) : 12 - 17
  • [8] Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma
    Fonseca de Jesus, Victor Hugo
    Guedes Camandaroba, Marcos Pedro
    Spina Donadio, Mauro Daniel
    Cabral, Audrey
    Muniz, Thiago Pimentel
    Leite, Luciana de Moura
    Sant'Ana, Lucas Ferreira
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (04) : 694 - 707
  • [9] Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
    Gemenetzis, Georgios
    Groot, Vincent P.
    Blair, Alex B.
    Laheru, Daniel A.
    Zheng, Lei
    Narang, Amol K.
    Fishman, Elliot K.
    Hruban, Ralph H.
    Yu, Jun
    Burkhart, Richard A.
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    [J]. ANNALS OF SURGERY, 2019, 270 (02) : 340 - 347
  • [10] ISRCTN, 2020, ISRCTN89500674 ESPAC
1234